Metabolic suppression identifies new antibacterial inhibitors under nutrient limitation

Is the GAIN Act a turning point in new antibiotic discovery?

(2013) Eric D. Brown   CANADIAN JOURNAL OF MICROBIOLOGY

10 x '20 Progress--Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of America

(2013) H. W. Boucher et al.   CLINICAL INFECTIOUS DISEASES

Speculative strategies for new antibacterials: all roads should not lead to Rome

(2013) Stuart Shapiro   JOURNAL OF ANTIBIOTICS

Fiji: an open-source platform for biological-image analysis

(2012) Johannes Schindelin et al.   NATURE METHODS

Considerations when prescribing trimethoprim-sulfamethoxazole

(2011) J. M.- W. Ho et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Evaluating the Sensitivity of Mycobacterium tuberculosis to Biotin Deprivation Using Regulated Gene Expression

(2011) Sae Woong Park et al.   PLoS Pathogens

Biotin synthesis begins by hijacking the fatty acid synthetic pathway

(2010) Steven Lin et al.   Nature Chemical Biology

Chemical genomics in Escherichia coli identifies an inhibitor of bacterial lipoprotein targeting

(2009) Ranjana Pathania et al.   Nature Chemical Biology

An integrated platform of genomic assays reveals small-molecule bioactivities

(2008) Shawn Hoon et al.   Nature Chemical Biology

Nucleotide Biosynthesis Is Critical for Growth of Bacteria in Human Blood

(2008) Shalaka Samant et al.   PLoS Pathogens